Cardiology
News
Test Lp(a) levels to inform ASCVD management: NLA statement
“The question in the scientific community is: What role does that particular biomarker play in terms of causing serious heart disease, stroke, and...
Conference Coverage
Patisiran benefits ATTR amyloidosis with cardiomyopathy: APOLLO-B
More details of the positive results with the RNAi therapeutic on functional capacity and quality of life were reported.
News
Warfarin associated with higher upper GI bleeding rates, compared with DOACs
The risk of upper gastrointestinal bleeding was higher in men taking warfarin.
Conference Coverage
MR and PET perform similarly for assessing CAD
Head-to-head comparison of rubidium PET and cardiac MR showed comparable performance for identifying coronary obstructions.
Conference Coverage
AI-assisted reading of echocardiograms readily detects severe aortic stenosis
Moderate and severe aortic stenosis is identified accurately on echocardiograms by artificial intelligence.
Conference Coverage
Evolocumab benefits accrue with longer follow-up: FOURIER OLE
Chief among the benefits was a reduction in cardiovascular mortality not observed in the pivotal trial that led to U.S. approval of evolocumab.
News
How do you live with COVID? One doctor’s personal experience
Early in 2020, Anne Peters, MD, caught COVID-19. The author of Medscape’s “Peters on Diabetes” column was sick in March 2020 before state-mandated...
Conference Coverage
No benefit of routine stress test POST-PCI in high-risk patients
Routine functional testing provided no advantage on clinical outcomes over standard care among high-risk patients after intervention, suggesting ‘...
Conference Coverage
PCI fails to beat OMT in ischemic cardiomyopathy: REVIVED-BCIS2
The surprising results of REVIVED-BCIS2 are likely to leave in place current guidelines for heart failure and revascularization.
Conference Coverage
Sacubitril/valsartan shows cognitive safety in heart failure: PERSPECTIVE
Patients with heart failure on sacubitril/valsartan had no signal of cognitive decline, compared with controls in PERSPECTIVE, a prospective,...